Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ursonic Acid

Copy Product Info
🥰Excellent
Catalog No. T3323Cas No. 6246-46-4
Alias TOS-BB-0966, Prunol, NSC4060, Malol, CCRIS 7123, 3-Ketoursolic acid

Ursonic Acid (TOS-BB-0966) belongs to the family of Ursane Triterpenes whose structure is based on the pentacyclic ursane skeleton. It has potential as HIV-1 Protease Inhibitor.

Ursonic Acid

Ursonic Acid

Copy Product Info
🥰Excellent
Purity: 99.48%
Catalog No. T3323Alias TOS-BB-0966, Prunol, NSC4060, Malol, CCRIS 7123, 3-Ketoursolic acidCas No. 6246-46-4
Ursonic Acid (TOS-BB-0966) belongs to the family of Ursane Triterpenes whose structure is based on the pentacyclic ursane skeleton. It has potential as HIV-1 Protease Inhibitor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$35In StockIn Stock
10 mg$48In StockIn Stock
25 mg$64In StockIn Stock
50 mg$89In StockIn Stock
100 mg$135In StockIn Stock
1 mL x 10 mM (in DMSO)$44In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.48%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Ursonic Acid AI Summary
Ursonic Acid exhibits a broad spectrum of bioactivity across various biological targets and cell lines. It demonstrates significant antiviral activity against HSV1 MacIntyre and HSV2 MS in African green monkey Vero cells, with IC50 values of 2.5 µg/mL and 8.0 µg/mL, respectively. Additionally, it shows inhibitory potential against glycogen phosphorylase A in rabbit muscle with an IC50 of 57000 nM and exhibits weak inhibition of aromatase in human placental microsomes with an IC50 greater than 500,000 nM. Ursonic Acid also acts as an HIV1 protease inhibitor at 37500 nM. In terms of cytotoxicity, Ursonic Acid inhibits the growth of several human cell lines, including NTUB1, AsPC1, MDA-MB-231, HepG2, and SMMC-7221, with IC50 values typically in the range of 21440 nM to 24500 nM. It also shows cytotoxicity against HeLa, MDA-MB-231, and SMMC7721 cell lines with IC50 values exceeding 40000 nM and demonstrates varying levels of growth inhibition in MCF7, HCT116, A549, THP1, and FR2 cells at 50 µM concentration. Furthermore, Ursonic Acid exhibits antimicrobial activity against various bacterial strains, including Escherichia coli, Pseudomonas fluorescens, Staphylococcus aureus, and Bacillus subtilis, with MIC values ranging from 31.2 to 62.5 µg/mL. It also shows activity against fungal strains such as Aspergillus niger, Candida albicans, and Candida tropicalis with higher MIC values. It inhibits cathepsin D with an IC50 of 6.41 µg/mL and reduces nitric oxide production in mouse RAW264.7 cells with an IC50 of 4940 nM. Additionally, Ursonic Acid exhibits antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 with a calculated selectivity index greater than 16.48, suggesting potential for treating malaria. Altogether, Ursonic Acid demonstrates multifaceted bioactivity, including antiviral, enzyme inhibition, antimicrobial, antiplasmodial, and cytotoxic properties, with variable potency across different targets and cell types..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Ursonic Acid (TOS-BB-0966) belongs to the family of Ursane Triterpenes whose structure is based on the pentacyclic ursane skeleton. It has potential as HIV-1 Protease Inhibitor.
SynonymsTOS-BB-0966, Prunol, NSC4060, Malol, CCRIS 7123, 3-Ketoursolic acid
Chemical Properties
Molecular Weight454.68
FormulaC30H46O3
Cas No.6246-46-4
Smiles[H][C@@]12[C@@H](C)[C@H](C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CCC(=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
Relative Density.1.09 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 58.8 mg/mL (129.32 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.4 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1993 mL10.9967 mL21.9935 mL109.9674 mL
5 mM0.4399 mL2.1993 mL4.3987 mL21.9935 mL
10 mM0.2199 mL1.0997 mL2.1993 mL10.9967 mL
20 mM0.1100 mL0.5498 mL1.0997 mL5.4984 mL
50 mM0.0440 mL0.2199 mL0.4399 mL2.1993 mL
100 mM0.0220 mL0.1100 mL0.2199 mL1.0997 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ursonic Acid | purchase Ursonic Acid | Ursonic Acid cost | order Ursonic Acid | Ursonic Acid chemical structure | Ursonic Acid formula | Ursonic Acid molecular weight